| P50 | author | Pierluigi Viale | Q113862183 |
| P2093 | author name string | Marco Borderi | |
| | Leonardo Calza | |
| | Eleonora Magistrelli | |
| | Vincenzo Colangeli | |
| | Linda Bussini | |
| | Elena Rosselli Del Turco | |
| | Nicolo' Rossi | |
| P2860 | cites work | Metabolic effects of indinavir in healthy HIV-seronegative men | Q28366603 |
| | The metabolic syndrome--a new worldwide definition | Q29615125 |
| | Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 |
| | Ageing and inflammation in patients with HIV infection. | Q30244296 |
| | Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study | Q33389734 |
| | Metabolic syndrome in older HIV-infected patients: data from the CORE50 cohort | Q33391970 |
| | Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters. | Q34283290 |
| | Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. | Q34663606 |
| | Changes in metabolic syndrome status after initiation of antiretroviral therapy | Q34674774 |
| | The metabolic effects of lopinavir/ritonavir in HIV-negative men | Q35194394 |
| | Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population | Q35206670 |
| | A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population. | Q35967926 |
| | Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals | Q36346699 |
| | High Prevalence of Metabolic Syndrome and Cardiovascular Disease Risk Among People with HIV on Stable ART in Southwestern Uganda | Q36475983 |
| | Prevalence of metabolic syndrome among HIV-infected patients in Ghana: A cross-sectional study. | Q36915645 |
| | Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV. | Q37350467 |
| | (2) Classification and diagnosis of diabetes | Q38299539 |
| | High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome | Q38447890 |
| | Targeting inflammation in metabolic syndrome. | Q38553529 |
| | Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV | Q38821848 |
| | Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study. | Q40955149 |
| | Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production | Q43295168 |
| | A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors | Q43613003 |
| | Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. | Q44470244 |
| | The assessment of metabolic syndrome in UK patients with HIV using two different definitions: CREATE 2 study | Q46052333 |
| | Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy | Q46183304 |
| | Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy | Q46317038 |
| | Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study | Q46546969 |
| | Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. | Q46626911 |
| | Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. | Q50761727 |
| | Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors. | Q50977031 |
| | Independent predictors of metabolic syndrome in HIV-infected patients. | Q51007084 |
| | Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy. | Q51496205 |
| | Prevalence of diabetes mellitus, hyperinsulinaemia and metabolic syndrome among 755 adult patients with HIV-1 infection | Q56987074 |
| P433 | issue | 3 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 110-117 | |
| P577 | publication date | 2017-04-19 | |
| P1433 | published in | HIV Clinical Trials | Q15756361 |
| P1476 | title | Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment | |
| P478 | volume | 18 | |